This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Genor Biopharma Holdings Balance Sheet Health
Financial Health criteria checks 6/6
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.86b |
| Equity | CN¥2.12b |
| Total liabilities | CN¥306.21m |
| Total assets | CN¥2.43b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6998's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥234.1M).
Long Term Liabilities: 6998's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥72.1M).
Debt to Equity History and Analysis
Debt Level: 6998 is debt free.
Reducing Debt: 6998 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6998 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6998 has sufficient cash runway for 2.7 years if free cash flow continues to reduce at historical rates of 42.7% each year.